Menu

Intellipharmaceutics International Inc. IPCIF

Full chart Compare
Set alert

Price alert · IPCIF

All alert types
0.15 0.00 (+0.00%)

Nov 25, 2024, 3:00 PM EST

0.15 Day range 0.15

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $255.07KExpenses → Selling, General & Admin: $561.05KExpenses → Research & Development: $2.15MExpenses → Other Operating Expenses: $206.06KExpenses → Interest Expense: $291.62KExpenses → Income Tax: $5.34KGross Profit → Expenses: $65.73KRevenue → Gross Profit: $65.73KNet Loss → Expenses: $2.89MOther Income$255.07KGross Profit$65.73KNet Loss$2.89MExpenses$3.21MSelling, General & Admin$561.05KResearch & Development$2.15MOther Operating Expenses$206.06KInterest Expense$291.62KIncome Tax$5.34KRevenue$65.73K

Latest period ending Nov 30, 2022 · select a line to chart its full history

IPCIF annual income statement
Fiscal yearFY 2022 Nov 30, 2022FY 2021 Nov 30, 2021FY 2020 Nov 30, 2020FY 2019 Nov 30, 2019FY 2018 Nov 30, 2018
65.73K01.40M3.48M1.71M
65.73K01.40M3.45M1.59M
-2.85M-4.17M-2.18M-7.83M-13.33M
-2.89M-5.15M-3.39M-8.08M-13.75M
-0.09-0.17-0.14-0.37-2.89
IPCIF annual balance sheet
Fiscal yearFY 2022 Nov 30, 2022FY 2021 Nov 30, 2021FY 2020 Nov 30, 2020FY 2019 Nov 30, 2019FY 2018 Nov 30, 2018
83.72K771.95K202.05K64.62K6.64M
1.43M2.10M3.39M3.80M11.47M
12.01M10.25M9.70M7.49M7.37M
2.33M1.92M2.11M1.90M1.79M
-10.58M-8.16M-6.31M-3.69M4.10M
IPCIF annual cash flow
Fiscal yearFY 2022 Nov 30, 2022FY 2021 Nov 30, 2021FY 2020 Nov 30, 2020FY 2019 Nov 30, 2019FY 2018 Nov 30, 2018
-1.39M-2.46M112.11K-6.66M-12.51M
500.00K025.32K-14.47K-101.18K
200.00K3.03M0100.90K17.35M
500.00K025.32K-14.47K-101.18K
-688.22K569.90K137.42K-6.58M4.74M